Sign in
4

Changes in Ownership

IN8BIO, INC. Filed Acc 0001209191-21-049157

Options or other derivatives

  • President, CEO and CFO acquired 220,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ho William Tai-Wei President, CEO and CFO 2021-07-29 Grant or award · Employee Stock Option (right to buy) +220,500 220,500 D: show line 1 in the form
Loading xslF345X03/doc4.xml…